Iburapid (Ibuprofen)

Iburapid, an NSAID, acts on prostaglandin-mediated pathways to relieve pain and inflammation.

• Mild to moderate pain: provides analgesic relief for headaches, musculoskeletal aches, and dental discomfort.
• Fever: reduces elevated body temperature associated with infections or inflammatory states.
• Osteoarthritis and rheumatoid arthritis: alleviates joint pain and swelling to improve mobility.
• Dysmenorrhea: eases menstrual cramps and associated discomfort.
• Headache: diminishes tension‑type and mild migraine pain.

• Ibuprofen reversibly inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. Reduced prostaglandin synthesis leads to lowered inflammation, pain signaling, and fever generation at peripheral and central sites.

Common Side Effects

• Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort.
• Headache or dizziness.
• Mild rash or itching.
• Elevated blood pressure in some individuals.
• Fluid retention or mild edema.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Severe allergic reactions such as anaphylaxis or angioedema.
• Acute renal impairment or failure.
• Hepatotoxicity with elevated liver enzymes.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiovascular events such as myocardial infarction or stroke, especially with high‑dose or prolonged use.

Before using Iburapid, consider the following safety measures.

• Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding.
• Use the lowest effective dose for the shortest duration needed.
• Avoid if known hypersensitivity to ibuprofen or other NSAIDs exists.
• Caution in renal or hepatic impairment; monitor function regularly.
• Do not combine with other NSAIDs, anticoagulants, or corticosteroids without medical advice.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Ibuprofen may interact with several medicines; review patient medication lists carefully.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Other NSAIDs or aspirin: heightened gastrointestinal toxicity.
• Lithium: elevated lithium serum levels and toxicity.
• Methotrexate: reduced renal clearance leading to toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
• Diuretics: risk of reduced renal perfusion.
• Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.
• Cyclosporine: may increase nephrotoxicity.
• Beta‑blockers: potential attenuation of blood pressure control.